David Dodwell

690 total citations
9 papers, 529 citations indexed

About

David Dodwell is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, David Dodwell has authored 9 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in David Dodwell's work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Lesions and Carcinomas (2 papers). David Dodwell is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Lesions and Carcinomas (2 papers). David Dodwell collaborates with scholars based in United Kingdom, United States and France. David Dodwell's co-authors include L Smith, Fiona Langlands, Kieran Horgan, Henri Roché, David Cameron, James L. Murray, Timothy Perren, John A. Glaspy, Nuhad K. Ibrahim and David Miles and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

David Dodwell

9 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dodwell United Kingdom 6 295 181 144 120 112 9 529
Michelle S. Miller United States 12 149 0.5× 284 1.6× 78 0.5× 26 0.2× 94 0.8× 27 517
David Surguladze United States 10 290 1.0× 212 1.2× 146 1.0× 78 0.7× 31 0.3× 21 531
Julie S. Barber-Rotenberg United States 8 204 0.7× 350 1.9× 65 0.5× 43 0.4× 22 0.2× 11 608
Beatriz Somovilla-Crespo Spain 10 123 0.4× 127 0.7× 158 1.1× 20 0.2× 52 0.5× 14 344
Jason L. Rowand United States 5 125 0.4× 251 1.4× 30 0.2× 62 0.5× 83 0.7× 6 369
Christian Wichmann Germany 16 155 0.5× 301 1.7× 73 0.5× 67 0.6× 109 1.0× 61 583
Jillian Wilhelmina Paulina Bracht Spain 14 283 1.0× 381 2.1× 63 0.4× 207 1.7× 22 0.2× 29 639
Daphne L. Farrington United States 12 155 0.5× 293 1.6× 111 0.8× 53 0.4× 133 1.2× 19 471
R. Dewji United Kingdom 7 528 1.8× 403 2.2× 77 0.5× 26 0.2× 24 0.2× 9 628
Mao Zhang China 8 167 0.6× 191 1.1× 110 0.8× 112 0.9× 54 0.5× 21 411

Countries citing papers authored by David Dodwell

Since Specialization
Citations

This map shows the geographic impact of David Dodwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dodwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dodwell more than expected).

Fields of papers citing papers by David Dodwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dodwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dodwell. The network helps show where David Dodwell may publish in the future.

Co-authorship network of co-authors of David Dodwell

This figure shows the co-authorship network connecting the top 25 collaborators of David Dodwell. A scholar is included among the top collaborators of David Dodwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dodwell. David Dodwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mannu, Gurdeep, Richard Berry, David Dodwell, et al.. (2024). Abstract GS02-05: Overview of Axillary Treatment in Early Breast Cancer: patient-level meta-analysis of long-term outcomes among 20,273 women in 29 randomised trials. Cancer Research. 84(9_Supplement). GS02–5. 1 indexed citations
2.
Dodwell, David, Carolyn Taylor, Paul McGale, et al.. (2019). Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials. Cancer Research. 79. 7 indexed citations
3.
Schaverien, Mark V., Sheila Stallard, David Dodwell, & Julie Doughty. (2013). Use of boost radiotherapy in oncoplastic breast-conserving surgery – A systematic review. European Journal of Surgical Oncology. 39(11). 1179–1185. 33 indexed citations
4.
Langlands, Fiona, Kieran Horgan, David Dodwell, & L Smith. (2013). Breast cancer subtypes: response to radiotherapy and potential radiosensitisation. British Journal of Radiology. 86(1023). 20120601–20120601. 90 indexed citations
5.
Coleman, R., Samantha Hinsley, R. Bell, et al.. (2013). Adjuvant therapy in early breast cancer with zoledronic acid (AZURE - BIG 01/04): Final efficacy analysis. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 2 indexed citations
6.
Miles, David, Henri Roché, Miguel Martín, et al.. (2011). Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer. The Oncologist. 16(8). 1092–1100. 208 indexed citations
7.
Procter, Marion, Thomas Suter, Evandro de Azambuja, et al.. (2010). Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial. Journal of Clinical Oncology. 28(21). 3422–3428. 179 indexed citations
9.
Loncaster, J. & David Dodwell. (2002). Adjuvant radiotherapy in breast cancer. Are there factors that allow selection of patients who do not require adjuvant radiotherapy following breast-conserving surgery for breast cancer?. PubMed. 93(2). 101–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026